Application and Impact of Antiviral Therapy for Patients with HBV-Related Hepatocellular Carcinoma Receiving Sorafenib and Lenvatinib Treatment.

Viruses · 2022 · PMC9692815 · PMID 36366452

Europe PMC DOI

hedged sentence

0.0010

closest p · 0.0× alpha

0.0010

boldest claim

The sentences

a significant trendp < 0.001actually significant

There was a significant trend in increased application of NUC therapy from 56.8% during 2012–2015, to 70.5% during 2016–2018, and to 84.7% during 2019–2022 ( p < 0.001, Figure 2 B).

also in 9,775 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.